Influenza vaccine is one of the most cost-effective interventions to prevent disease, hospitalisation and death, yet coverage rates are variable among high risk populations. In 2016 there were 83,092 notifications of laboratory confirmed influenza nationally. It has been estimated that 9% of admissions in the elderly and 19% of admissions in non-elderly adults with risk factors could be prevented with higher immunisation coverage. This project will build on a pilot program commenced in 2017, of an outreach, nurse led mobile immunisation service to vulnerable populations (refugees, asylum seekers, homeless, those in crisis, institutionalised, those from culturally and linguistically diverse backgrounds and Aboriginal and Torres Strait Islander populations. This project will expand its program in 2018 and assess the following outcomes; characteristics of populations reached, risk factors for severe influenza, uptake rate and prevention of hospital presentation.
Public health, infectious diseases, influenza, immunisation
Central Clinical School